Skip to main content

WPI 2287 Pill - white capsule/oblong, 23mm

Pill with imprint WPI 2287 is White, Capsule/Oblong and has been identified as Propafenone Hydrochloride Extended-Release 425 mg. It is supplied by Actavis Pharma, Inc.

Propafenone is used in the treatment of Atrial Fibrillation; Ventricular Tachycardia; Wolff-Parkinson-White Syndrome; Atrial Flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2287

Propafenone hydrochloride extended-release 425 mg WPI 2287
Propafenone hydrochloride extended-release 425 mg WPI 2287

Propafenone Hydrochloride Extended-Release

WPI 2287
425 mg
23.00 mm
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
ferrosoferric oxide, gelatin, hypromelloses, magnesium stearate, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.